Home > Financial Ratios > MANKIND PHARMA
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 21.2241.65-15.6018.7817.23

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 21.22 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202521.22
Mar202441.65
Mar2023-15.60
Mar202218.78
Mar202117.23

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 21.22
-49.05
Mar2024 41.65
Positive
Mar2023 -15.6
Negative
Mar2022 18.78
9.00
Mar2021 17.23 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹106,496.2 Cr 0.1% 6.1% 6.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹387,792.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹127,124.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,700.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,868.0 Cr 5.3% 7.9% -2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.1%

6.1%

6.2%

SENSEX

1.5%

1.6%

0.4%


You may also like the below Video Courses